HS Pharma is exploring potential applications for bone regeneration in orthopedics and oral health.

The initial patent for these applications was filed with the US Patent and Trade Office in April 2016, and HS Pharmaceuticals is currently exploring multiple medical and FDA pathways to bring the technology to market.